Helmy Eltoukhy - 31 Mar 2025 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
Co-Chief Executive Officer, Director
Signature
/s/ John G. Saia, as attorney-in-fact for Helmy Eltoukhy
Issuer symbol
GH
Transactions as of
31 Mar 2025
Net transactions value
-$620,507
Form type
4
Filing time
02 Apr 2025, 17:24:50 UTC
Previous filing
18 Mar 2025
Next filing
02 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH Common Stock Options Exercise $0 +4,814 +0.2% $0.000000 2,399,895 31 Mar 2025 Direct
transaction GH Common Stock Tax liability $103,944 -2,440 -0.1% $42.60 2,397,455 31 Mar 2025 Direct F1
transaction GH Common Stock Options Exercise $0 +23,998 +1% $0.000000 2,421,453 01 Apr 2025 Direct
transaction GH Common Stock Tax liability $516,563 -12,163 -0.5% $42.47 2,409,290 01 Apr 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH Restricted Stock Units Options Exercise $0 -4,814 -25% $0.000000 14,444 31 Mar 2025 Common Stock 4,814 $0.000000 Direct F2, F3
transaction GH Restricted Stock Units Options Exercise $0 -23,998 -13% $0.000000 167,980 01 Apr 2025 Common Stock 23,998 $0.000000 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 This represents a restricted stock unit award granted on March 12, 2025 that vests in four equal installments on the last day of each calendar quarter, March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.
F3 Not applicable for Restricted Stock Units.
F4 This represents a restricted stock unit award granted on March 18, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on January 1, 2025 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.